resveratrol has been researched along with Amentia in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Joon, S; Kamal, MA; Shen, B; Simal-Gandara, J; Singla, RK; Sinha, B; Xiao, J | 1 |
Ashabi, G; Nikbakhtzadeh, M; Shaerzadeh, F | 1 |
Lange, KW; Li, S | 1 |
Barbagallo, M; Dominguez, LJ | 1 |
Howe, PRC; Thaung Zaw, JJ; Wong, RHX | 1 |
Howes, MJ; Simmonds, MS | 1 |
Evans, HM; Howe, PR; Wong, RH | 1 |
Collins, MA; Das, DK; Gray, MO; Korthuis, RJ; Mukamal, KJ; Neafsey, EJ; Parks, DA | 1 |
Davies, P; Dreses-Werringloer, U; Marambaud, P; Vingtdeux, V; Zhao, H | 1 |
Camins, A; Gutierrez-Cuesta, J; Pallàs, M; Tajes, M; Verdaguer, E | 1 |
9 review(s) available for resveratrol and Amentia
Article | Year |
---|---|
Current trends in natural products for the treatment and management of dementia: Computational to clinical studies.
Topics: Biological Products; Curcumin; Dementia; Humans; Resveratrol; Retrospective Studies | 2023 |
Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dementia; Humans; Models, Theoretical; Neurons; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; TOR Serine-Threonine Kinases | 2021 |
Resveratrol, pterostilbene, and dementia.
Topics: Alzheimer Disease; Animals; Antioxidants; Biological Transport; Blood-Brain Barrier; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Models, Animal; Humans; Maze Learning; Neuroprotective Agents; Resveratrol; Stilbenes | 2018 |
Nutritional prevention of cognitive decline and dementia.
Topics: Antioxidants; Autophagy; Caffeine; Catechin; Central Nervous System Stimulants; Chocolate; Cognitive Dysfunction; Curcumin; Dementia; Diet; Fatty Acids, Omega-3; Garlic; Ginkgo biloba; Healthy Aging; Humans; Inflammation; Magnesium; Oxidative Stress; Phytoestrogens; Phytotherapy; Resveratrol; Tea; Vitamins | 2018 |
Postmenopausal health interventions: Time to move on from the Women's Health Initiative?
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Coronary Disease; Dementia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Phytoestrogens; Postmenopause; Resveratrol; Risk Assessment; Time Factors; Women's Health | 2018 |
The role of phytochemicals as micronutrients in health and disease.
Topics: Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Dementia; Diabetes Mellitus; Humans; Micronutrients; Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Stilbenes; Tea; Vitis; Wine | 2014 |
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Central Nervous System Depressants; Dementia; Ethanol; Humans; Neuroprotective Agents; Nitric Oxide; Protein Kinase C; Resveratrol; Stilbenes | 2009 |
Therapeutic potential of resveratrol in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Dementia; Flavonoids; Humans; Nerve Degeneration; Phenols; Polyphenols; Resveratrol; Stilbenes; Wine | 2008 |
Modulation of sirtuins: new targets for antiageing.
Topics: Aging; Animals; Dementia; Enzyme Inhibitors; Humans; Models, Biological; Reactive Oxygen Species; Resveratrol; Sirtuins; Stilbenes | 2008 |
1 trial(s) available for resveratrol and Amentia
Article | Year |
---|---|
Clinical Evaluation of Effects of Chronic Resveratrol Supplementation on Cerebrovascular Function, Cognition, Mood, Physical Function and General Well-Being in Postmenopausal Women-Rationale and Study Design.
Topics: Affect; Aged; Aged, 80 and over; Cerebrovascular Circulation; Clinical Protocols; Cognition; Cognition Disorders; Dementia; Dietary Supplements; Double-Blind Method; Female; Health Status; Humans; Mental Health; Middle Aged; Neuropsychological Tests; New South Wales; Phytoestrogens; Postmenopause; Regional Blood Flow; Research Design; Resveratrol; Risk Factors; Stilbenes; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2016 |